Comparison of alendronate and raloxifene in postmenopausal women with osteoporosis

ISSN： 1473-0804

Source： Climacteric, Vol.14, Iss.3, 2011-06, pp. : 369-377

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical efficacy of raloxifene in postmenopausal women

By Agnusdei D.

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 85, Iss. 1, 1999-07 ,pp. : 43-46

Elsevier

Access to resources Recommend Favorite

Adherence and persistence in patients with postmenopausal osteoporosis treated with raloxifene

By Ziller V. Wetzel K. Kyvernitakis I. Seker-Pektas B. Hadji P.

Climacteric, Vol. 14, Iss. 2, 2011-04 ,pp. : 228-235

Informa Healthcare

Access to resources Recommend Favorite

Effects of raloxifene therapy on the anticoagulant system in postmenopausal women

By Azevedo G. D. Franco R. F. Baggio M. S. Maranhão T. M. O. Ferriani R. A. Silva de Sá M. F.

Climacteric, Vol. 6, Iss. 2, 2003-06 ,pp. : 140-145

Informa Healthcare

Access to resources Recommend Favorite

Effects of raloxifene treatment on uterine leiomyomas in postmenopausal women

By Palomba S. Sammartino A. Di Carlo C. Affinito P. Zullo F. Nappi C.

Fertility and Sterility, Vol. 76, Iss. 1, 2001-07 ,pp. : 38-43

Elsevier

Access to resources Recommend Favorite

Effect of raloxifene on sexual function in postmenopausal women

By Kessel B. Nachtigall L. Plouffe L. Siddhanti S. Rosen A. Parsons A.

Climacteric, Vol. 6, Iss. 3, 2003-09 ,pp. : 248-256

Informa Healthcare

Access to resources Recommend Favorite